Theralase Technologies Inc. (CVE:TLT – Get Free Report) shares were up 24.5% during trading on Monday . The stock traded as high as C$0.36 and last traded at C$0.31. Approximately 645,781 shares traded hands during mid-day trading, an increase of 58% from the average daily volume of 407,451 shares. The stock had previously closed at C$0.25.
Theralase Technologies Stock Performance
The company has a market cap of C$75.50 million, a P/E ratio of -15.83 and a beta of -0.35. The business has a 50 day moving average price of C$0.17 and a two-hundred day moving average price of C$0.19. The company has a debt-to-equity ratio of 14.85, a quick ratio of 3.40 and a current ratio of 1.91.
About Theralase Technologies
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Featured Articles
- Five stocks we like better than Theralase Technologies
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Trump’s Hand-Written Letter Will Shock his Haters
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- End of America update
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
